Does MaineCare (Medicaid) Cover Sublocade?

Yes, MaineCare may cover Sublocade for eligible members receiving treatment for opioid use disorder. MaineCare is Maine’s Medicaid program, and its coverage policies allow qualifying members to receive extended-release buprenorphine when specific clinical and billing requirements are met.

However, MaineCare coverage for Sublocade is not necessarily automatic. Coverage may depend on factors such as:

• Whether Sublocade is billed through the medical or pharmacy benefit
• Whether the prescribing provider documents the required clinical criteria
• The member’s previous or current use of buprenorphine
• Whether prior authorization is required
• Whether the provider and medication supplier participate with MaineCare
• The member’s individual MaineCare eligibility and benefits

Portland Treatment can help people seeking opioid addiction treatment in Maine understand their available treatment options and determine how their MaineCare benefits may apply.

What Is Sublocade?

Sublocade is the brand name for an extended-release form of buprenorphine. It is administered as a subcutaneous injection by a qualified healthcare provider and releases buprenorphine gradually over approximately one month.

Sublocade is used to treat moderate to severe opioid use disorder in adults who have started treatment with transmucosal buprenorphine or who are already receiving buprenorphine treatment. It should be used as part of a complete treatment plan that includes counseling and psychosocial support.

Unlike daily buprenorphine tablets or films, the Sublocade shot does not require the patient to remember a dose every day. This may make it helpful for people who experience:

• Difficulty taking medication consistently
• Concerns about losing medication
• Unstable housing or transportation
• Medication diversion concerns
• Frequent cravings between daily doses
• A desire for a more discreet treatment option

Sublocade must be administered by a healthcare professional. The injection is not given directly to the patient to take home.

Does MaineCare Cover the Sublocade Shot?

MaineCare does provide a pathway for coverage of extended-release buprenorphine, including Sublocade, when the member meets MaineCare’s clinical criteria.

According to the Maine Department of Health and Human Services, providers may bill extended-release buprenorphine through the MaineCare medical benefit without prior authorization when their documentation meets the state’s clinical-use criteria. When Sublocade is billed through the pharmacy benefit, prior authorization is still required.

This distinction is important:

Coverage rules can change, and approval remains dependent on the individual member’s circumstances. A treatment provider should verify MaineCare benefits before scheduling the injection.

What Are MaineCare’s Requirements for Sublocade?

MaineCare identifies buprenorphine/naloxone films and oral buprenorphine/naloxone tablets as preferred, cost-effective medications for opioid use disorder. However, some MaineCare members may qualify for extended-release buprenorphine when a long-acting injection is clinically appropriate.

A provider may need to document why Sublocade is appropriate for the member. Depending on the person’s circumstances, relevant considerations may include:

• A diagnosis of opioid use disorder
• Current or previous treatment with buprenorphine
• Clinical appropriateness of extended-release buprenorphine
• Difficulty adhering to a daily medication schedule
• Risk that medication could be lost, stolen, misused, or diverted
• Challenges maintaining a consistent medication supply
• A history of unsuccessful treatment with preferred buprenorphine products
• A need for greater treatment structure or medication stability

Meeting one of these considerations does not guarantee approval. The prescribing professional must evaluate the individual and follow the current MaineCare clinical and billing requirements.

Does MaineCare Require Prior Authorization for Sublocade?

It depends on how the medication is billed.

Sublocade Through the Medical Benefit

MaineCare has stated that extended-release buprenorphine may be billed through the medical benefit without prior authorization when the provider’s records meet the required clinical-use criteria.

The provider is still responsible for maintaining accurate documentation. Lack of proper documentation could lead to payment problems or a later review of the claim.

Sublocade Through the Pharmacy Benefit

When extended-release buprenorphine is billed through the MaineCare pharmacy benefit, prior authorization is required. The provider may need to submit clinical information showing why Sublocade is medically appropriate.

Prior authorization is a request for MaineCare to approve coverage before the medication is dispensed or administered. It is not the same as a denial. It simply means MaineCare requires additional information before agreeing to pay for the medication.

How Much Does Sublocade Cost With MaineCare?

The amount a MaineCare member pays for Sublocade can vary based on:

• Current MaineCare eligibility
• Whether the provider accepts MaineCare
• How the medication is ordered and billed
• Whether prior authorization is approved
• Whether other insurance coverage applies
• The services provided during the appointment

Some qualifying MaineCare members may have little or no out-of-pocket responsibility for covered opioid use disorder treatment. However, coverage should always be verified before treatment begins.

Calling the number on the MaineCare member card or speaking with an admissions representative can help clarify:

• Whether Sublocade is covered
• Whether authorization is needed
• Which providers are in network
• Whether there is a copayment
• Whether related counseling or outpatient services are covered

Does MaineCare Cover Medication-Assisted Treatment?

MaineCare may cover multiple forms of medication-assisted treatment, also called MAT or medications for opioid use disorder.

Maine’s treatment resources identify medications such as buprenorphine, methadone, and naltrexone as options that may be used to support opioid detoxification and ongoing recovery.

Depending on medical need, MaineCare coverage for opioid addiction treatment may include:

• Buprenorphine
• Buprenorphine/naloxone products
• Sublocade
• Methadone treatment
• Naltrexone or Vivitrol
• Medical appointments
• Behavioral health assessments
• Individual therapy
• Group counseling
• Case management
• Peer recovery services
• Intensive outpatient treatment
• Partial hospitalization services

Not every service or medication is appropriate for every person. A clinical assessment can help determine which MaineCare-covered addiction treatment services may provide the best level of support.

Is Sublocade the Same as Suboxone?

Sublocade and Suboxone both contain buprenorphine, but they are not the same medication.

MaineCare identifies brand-name Suboxone film and generic buprenorphine/naloxone tablets as preferred covered products for opioid use disorder. Sublocade may still be covered when the extended-release formulation is clinically appropriate.

Can You Start Sublocade Immediately?

A person cannot simply obtain Sublocade and administer it independently. A healthcare professional must evaluate the patient and initiate or confirm tolerance to buprenorphine.

Current prescribing information indicates that Sublocade may be used for adults who have started treatment with a transmucosal buprenorphine product or who are already being treated with buprenorphine. The exact initiation process should be determined by the prescribing professional.

Before beginning Sublocade, the provider may evaluate:

• Recent opioid use
• Current withdrawal symptoms
• Previous buprenorphine treatment
• Other prescription medications
• Alcohol or benzodiazepine use
• Liver health
• Pregnancy or breastfeeding
• Risk of respiratory depression
• The patient’s recovery environment

Patients should not attempt to switch medications or alter their buprenorphine dosage without medical guidance.

What Are the Potential Benefits of Sublocade?

For some people with opioid use disorder, a monthly buprenorphine injection may provide greater stability than a daily medication.

Potential benefits may include:

Consistent Medication Delivery

Sublocade releases buprenorphine gradually throughout the month. This eliminates the need to take a tablet or film every day.

Fewer Missed Doses

Because the injection is administered by a provider, patients do not have to remember daily medication.

Reduced Diversion Risk

Once Sublocade has been administered, it cannot be sold, shared, misplaced, or stolen in the same way that take-home medication can.

Greater Privacy

Some people prefer receiving a monthly injection rather than storing medication at home or taking it around family members, roommates, or coworkers.

Continued Craving and Withdrawal Support

Buprenorphine can help reduce opioid withdrawal symptoms and cravings while supporting continued participation in recovery.

Increased Treatment Structure

Regular provider appointments give the care team opportunities to monitor progress, discuss side effects, and address emerging recovery needs.

Does Sublocade Cause Side Effects?

Sublocade can cause side effects and is not appropriate for everyone. Commonly reported effects may include:

• Injection-site pain or irritation
• Constipation
• Headache
• Nausea
• Fatigue
• Vomiting
• Increased liver enzyme levels

Buprenorphine can also cause serious breathing problems, particularly when combined with alcohol, benzodiazepines, sedatives, or other substances that slow the central nervous system. Patients should tell their provider about every medication and substance they use.

Seek emergency help for symptoms such as:

• Slow or difficult breathing
• Severe sleepiness
• Loss of consciousness
• Confusion
• Blue or gray lips
• Inability to wake up

People receiving treatment for opioid use disorder should also discuss access to naloxone with their healthcare provider.

Does MaineCare Cover Counseling With Sublocade?

MaineCare may cover behavioral health and substance use disorder services that accompany medication treatment. The exact services available depend on the provider, level of care, medical necessity, and the member’s MaineCare benefits.

Sublocade is intended to be part of a broader treatment plan that includes counseling and psychosocial support. Medication can address opioid cravings and withdrawal, while therapy may help a person address:

• Triggers for opioid use
• Co-occurring mental health symptoms
• Trauma
• Family conflict
• Employment or housing concerns
• Relapse warning signs
• Stress-management skills
• Recovery planning

A comprehensive program may combine medication management with individual counseling, group therapy, case management, and peer support.

Can MaineCare Cover Outpatient Opioid Treatment?

MaineCare may cover outpatient substance use disorder treatment when the services are medically necessary and provided by a participating program.

Depending on the individual’s needs, outpatient care may involve:

• Standard outpatient counseling
• Intensive outpatient programming
• Partial hospitalization programming
• Medication management
• Case management
• Recovery support
• Drug and alcohol testing
• Coordination with outside Sublocade providers

Outpatient treatment allows many people to remain at home while attending structured addiction services during the day or evening.

How to Verify MaineCare Coverage for Sublocade

Before beginning treatment, complete these steps:

1. Confirm that your MaineCare coverage is active.
   Eligibility can change, so confirm your current status rather than relying on an older member card.
2. Ask whether the provider accepts MaineCare.
   A medication may be covered, but the administering provider must also be eligible to bill MaineCare.
3. Determine whether Sublocade will be billed medically or through a pharmacy.
   This may affect whether prior authorization is required.
4. Complete a clinical assessment.
   The provider must determine whether extended-release buprenorphine is appropriate.
5. Submit prior authorization when required.
   The prescribing office or pharmacy generally handles this process.
6. Verify related treatment services.
   Ask whether MaineCare covers counseling, outpatient programming, assessments, testing, and medication-management visits.
7. Request an explanation of any denial.
   A denial may result from missing documentation, inactive eligibility, billing errors, or failure to meet the applicable criteria.

What Should I Do If MaineCare Denies Sublocade?

A MaineCare denial does not always mean Sublocade can never be covered.

The patient or provider may be able to:

• Confirm that the claim was billed under the correct benefit
• Submit missing clinical records
• Correct inaccurate member information
• Request prior authorization
• Ask for reconsideration
• Follow the available appeal process
• Discuss another covered buprenorphine formulation
• Begin with a preferred medication before requesting Sublocade
• Coordinate with another qualified provider

Do not stop buprenorphine or return to opioid use because of an insurance delay. Ask the treatment team about temporary medication and support options while the coverage issue is addressed.

Finding MaineCare Addiction Treatment Near Portland, Maine

Searching for MaineCare addiction treatment in Maine can feel overwhelming. Insurance terminology, authorization rules, and provider requirements can create unnecessary barriers at a time when receiving treatment is especially important.

Portland Treatment provides structured addiction treatment for adults in Maine and can help individuals explore treatment options that may be available through MaineCare.

Our team can assist with:

• MaineCare insurance verification
• Substance use disorder assessments
• Outpatient addiction treatment
• Intensive outpatient programming
• Partial hospitalization programming
• Individual and group counseling
• Recovery planning
• Coordination of medication-assisted treatment
• Referrals to qualified Sublocade providers when appropriate

Coverage cannot be guaranteed until benefits and clinical eligibility have been reviewed.

Frequently Asked Questions

Is Sublocade covered by Medicaid?

Medicaid programs may cover Sublocade, but requirements differ by state. In Maine, Medicaid is called MaineCare. MaineCare has established clinical and billing requirements for extended-release buprenorphine coverage.

Is Sublocade covered by MaineCare?

MaineCare may cover Sublocade for qualifying members. Coverage depends on medical necessity, provider documentation, the billing method, and whether prior authorization is required.

Does MaineCare require prior authorization for Sublocade?

MaineCare states that prior authorization is required when extended-release buprenorphine is billed through the pharmacy benefit. Prior authorization may not be required under the medical benefit when the provider documents that the member meets MaineCare’s clinical criteria.

Does MaineCare cover Suboxone?

MaineCare identifies brand-name Suboxone film and generic buprenorphine/naloxone tablets as preferred covered medications for opioid use disorder.

Can I get Sublocade without taking Suboxone first?

Sublocade is used after a patient has initiated treatment with transmucosal buprenorphine or when the patient is already receiving buprenorphine. A qualified healthcare provider must determine the appropriate initiation process.

Is Sublocade free with MaineCare?

Some MaineCare members may owe little or nothing for covered treatment, but costs depend on eligibility, the provider, the billing pathway, and the individual benefit arrangement. Benefits should be verified before treatment.

Does Portland Treatment accept MaineCare?

Contact Portland Treatment directly to verify current MaineCare participation, available services, admission requirements, and how your individual benefits may apply.

Can Portland Treatment prescribe Sublocade?

The availability of specific medications and prescribing services should be confirmed directly with the admissions team. When a medication is not administered on-site, treatment programs may be able to coordinate care with an outside medical provider.

Verify Your MaineCare Benefits With Portland Treatment

MaineCare can reduce one of the most common barriers to opioid addiction treatment: cost. If you are considering Sublocade, Suboxone, or another medication for opioid use disorder, the first step is determining what your MaineCare plan covers and which services are clinically appropriate.

Portland Treatment can help verify your MaineCare benefits, explain available outpatient treatment options & medication assisted treatment options, and coordinate the next steps in your recovery.

Contact Portland Treatment today to learn more about MaineCare addiction treatment near Portland, Maine.

Sources

Food and Drug Administration. (2024, December 26). Information about medications for opioid use disorder (MOUD). U.S. Department of Health and Human Services. https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud

Food and Drug Administration. (2023). Sublocade (buprenorphine extended-release) injection prescribing information. U.S. Department of Health and Human Services. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209819s028lbl.pdf

Maine Department of Health and Human Services. (2023, June 23). Coverage of medications for treatment of opioid use disorder in pregnancy. Office of MaineCare Services. https://www.maine.gov/dhhs/oms/providers/provider-bulletins/coverage-medications-treatment-opioid-use-disorder-pregnancy-2023-06-23

Maine Department of Health and Human Services. (2023, June 23). Extended-release buprenorphine clinical use criteria. Office of MaineCare Services. https://www.maine.gov/dhhs/oms/providers/provider-bulletins/extended-release-buprenorphine-clinical-use-criteria-2023-06-23

Maine Department of Health and Human Services. (n.d.). Pharmacy services. Office of MaineCare Services. https://www.maine.gov/dhhs/oms/providers/pharmacy-services

Substance Abuse and Mental Health Services Administration. (2026, April 6). What is buprenorphine? Side effects, treatment, and use. U.S. Department of Health and Human Services. https://www.samhsa.gov/substance-use/treatment/options/buprenorphine

Substance Abuse and Mental Health Services Administration. (2025, August 25). Treatment options for substance use disorder. U.S. Department of Health and Human Services. https://www.samhsa.gov/substance-use/treatment/options

Substance Abuse and Mental Health Services Administration. (2021, April 6). Buprenorphine quick start guide. U.S. Department of Health and Human Services. https://library.samhsa.gov/product/buprenorphine-quick-start-guides/pep21-02-001